Signum, GSK enter collaborative agreement
PRINCETON, N.J. — Biotechnology company Signum Biosciences has entered a collaborative agreement with GlaxoSmithKline whereby GSK will receive the exclusive right to Signum’s proprietary phosphatase screening technology.
GSK and Signum said the companies "will undertake a broad research and development collaboration to screen and identify phosphoprotein phosphatase 2A (PP2A) targeted compounds, including those bridging the link between PP2A methylation and tau hyperphosphorylation." As part of the agreement, Signum will be provided research support and milestone payments as GSK forges ahead with its research and development activities in neurosciences.
"GSK is an ideal partner for Signum," Signum president Maxwell Stock said. "We will develop therapeutics using our phosphatase screening technology in an alliance that utilizes the expertise of both companies. We are proud to be working in collaboration with a leading pharmaceutical company in innovative research and development. Collaborations such as these allow partners to share knowledge, expertise and resources and thereby provide a highly effective way of progressing cutting edge research and developing an effective drug."
QS/1, ECRS introduce point-of-sale, pharmacy management interface
BOONE, N.C. — QS/1 and ECR Software have released an interface that links the ECRS Catapult point-of-sale system and QS/1’s NRx pharmacy management system, the two companies said.
The companies said they developed the interface to improve communication between the POS system and the pharmacy management system and merge pharmacy and grocery department business data into a centralized repository. Star Super Market and Discount Pharmacy, a chain that operates four stores in the Huntsville, Ala., area served as the site for a pilot of the product.
"I believe the relationship between ECRS and QS/1 will helpprovide the best customer service, drive loyalty and prevent costly errors by consolidating our Catapult point-of-sale system used in the pharmacy and grocery with our QS/1 NRx pharmacy management system," Star Super Market and Discount Pharmacy chief information officer James Ahlschlager said. "With tighter integration and through the incorporation of new technologies, we are striving to make shopping easier for our customers."
Diplomat Specialty Pharmacy earns recognition from MichBio; spotlighted in Pure Michigan video
FLINT, Mich. — Diplomat Specialty Pharmacy was recognized by MichBio, a biosciences industry trade association and the official Michigan affiliate of the Biotechnology Industry Organization.
Diplomat received the Good to Great award from the organization, which recognized "as a company whose business concept, entrepreneurialism, leadership, work ethic and products have melded in just the right way to produce a leap forward in the past year," MichBio president and CEO Stephen Rapundalo said. "MichBio views Diplomat as a strong and visible indicator that our industry is thriving here in Michigan and that the outlook for the state’s biosciences sector seems positive. Success breeds success, and Diplomat’s tremendous strides in commercialization will serve as a beacon for others."
Diplomat president and CEO Phil Hagerman said this achievement was made possible by the company’s staff and its healthcare partners.
In related news, Diplomat also was featured in a video produced by the Michigan Economic Development Center and the city of Flint, called Pure Michigan, which illustrated how Flint is transforming itself into a leading center of commerce and provide a glimpse of the future Michigan, Diplomat said. The video highlights the strides and development in the city, which was made possible by Diplomat, as well as General Motors.
To view the video, click here.